Agios’s $345 Million Repurchase Agreement With Bristol-Myers Squibb Company

Wachtell, Lipton, Rosen & Katz advised Agios Pharmaceuticals on the deal.Agios Pharmaceuticals, Inc. entered into a Share Repurchase Agreement with Bristol-Myers Squibb Company, pursuant to which Agios…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here